ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17
Tài liệu tham khảo
Hoeper, 2021, Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial, Lancet Respir Med, 9, 573, 10.1016/S2213-2600(20)30532-4
Southgate, 2020, Molecular genetic framework underlying pulmonary arterial hypertension, Nat Rev Cardiol, 17, 85, 10.1038/s41569-019-0242-x
Badesch, 2009, Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol, J Rheumatol, 36, 2244, 10.3899/jrheum.081277
Hoffmann, 2020, Evolution of pulmonary hypertension during severe sustained hypoxia, Circulation, 141, 1504, 10.1161/CIRCULATIONAHA.119.045192
Ghofrani, 2006, Hypoxia- and non-hypoxia-related pulmonary hypertension—established and new therapies, Cardiovasc Res, 72, 30, 10.1016/j.cardiores.2006.07.025
Hassoun, 2021, Pulmonary arterial hypertension, N Engl J Med, 385, 2361, 10.1056/NEJMra2000348
Penaloza, 2007, The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness, Circulation, 115, 1132, 10.1161/CIRCULATIONAHA.106.624544
Song, 2018, STIM2 (stromal interaction molecule 2)-mediated increase in resting cytosolic free Ca2 concentration stimulates PASMC proliferation in pulmonary arterial hypertension, Hypertension, 71, 518, 10.1161/HYPERTENSIONAHA.117.10503
Montani, 2014, Targeted therapies in pulmonary arterial hypertension, Pharmacol Ther, 141, 172, 10.1016/j.pharmthera.2013.10.002
Nishikura, 2016, A-to-I editing of coding and non-coding RNAs by ADARs, Nat Rev Mol Cell Biol, 17, 83, 10.1038/nrm.2015.4
Athanasiadis, 2004, Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome, PLoS Biol, 2, e391, 10.1371/journal.pbio.0020391
Orlandi, 2012, Activity regulation of adenosine deaminases acting on RNA (ADARs), Mol Neurobiol, 45, 61, 10.1007/s12035-011-8220-2
Nishikura, 2010, Functions and regulation of RNA editing by ADAR deaminases, Annu Rev Biochem, 79, 321, 10.1146/annurev-biochem-060208-105251
Nie, 2004, Subcellular distribution of ADAR1 isoforms is synergistically determined by three nuclear discrimination signals and a regulatory motif, J Biol Chem, 279, 13249, 10.1074/jbc.M312753200
Fritz, 2009, RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1, Mol Cell Biol, 29, 1487, 10.1128/MCB.01519-08
Strehblow, 2002, Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain, Mol Biol Cell, 13, 3822, 10.1091/mbc.e02-03-0161
Ishizuka, 2019, Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade, Nature, 565, 43, 10.1038/s41586-018-0768-9
Fei, 2016, ADAR1-mediated RNA editing, a novel mechanism controlling phenotypic modulation of vascular smooth muscle cells, Circ Res, 119, 463, 10.1161/CIRCRESAHA.116.309003
Jiang, 2018, ADAR1 silencing-induced HUVEC apoptosis is mediated by FGFR2 under hypoxia stress, Drug Des Dev Ther, 12, 4181, 10.2147/DDDT.S181312
Ben-Zvi, 2013, F11R expression upon hypoxia is regulated by RNA editing, PLoS One, 8, 10.1371/journal.pone.0077702
Ma, 2019, ADAR1 promotes robust hypoxia signaling via distinct regulation of multiple HIF-1α-inhibiting factors, EMBO Rep, 20, 10.15252/embr.201847107
Li, 2018, The biogenesis, functions, and challenges of circular RNAs, Mol Cell, 71, 428, 10.1016/j.molcel.2018.06.034
Chen, 2021, The bioinformatics toolbox for circRNA discovery and analysis, Briefings Bioinf, 22, 1706, 10.1093/bib/bbaa001
Kristensen, 2019, The biogenesis, biology and characterization of circular RNAs, Nat Rev Genet, 20, 675, 10.1038/s41576-019-0158-7
Zhou, 2020, Circular RNA: metabolism, functions and interactions with proteins, Mol Cancer, 19, 172, 10.1186/s12943-020-01286-3
Ivanov, 2015, Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals, Cell Rep, 10, 170, 10.1016/j.celrep.2014.12.019
Abe, 2010, Formation of plexiform lesions in experimental severe pulmonary arterial hypertension, Circulation, 121, 2747, 10.1161/CIRCULATIONAHA.109.927681
Halbert, 2007, High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung, Hum Gene Ther, 18, 344, 10.1089/hum.2006.182
Wang, 2021, Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes, Cell Mol Immunol, 18, 1871, 10.1038/s41423-021-00729-1
Nie, 2020, Periostin: a potential therapeutic target for pulmonary hypertension?, Circ Res, 127, 1138, 10.1161/CIRCRESAHA.120.316943
Poliseno, 2010, A coding-independent function of gene and pseudogene mRNAs regulates tumour biology, Nature, 465, 1033, 10.1038/nature09144
Chen, 2020, Comprehensive review and assessment of computational methods for predicting RNA post-transcriptional modification sites from RNA sequences, Briefings Bioinf, 21, 1676, 10.1093/bib/bbz112
Dai, 2018, Identification of YTH domain-containing proteins as the readers for N1-methyladenosine in RNA, Anal Chem, 90, 6380, 10.1021/acs.analchem.8b01703
Liu, 2022, tRNA-m(1)A modification promotes T cell expansion via efficient MYC protein synthesis, Nat Immunol, 23, 1433, 10.1038/s41590-022-01301-3
Mathews, 2004, Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure, Proc Natl Acad Sci U S A, 101, 7287, 10.1073/pnas.0401799101
Armaos, 2021, catRAPID omics v2.0: going deeper and wider in the prediction of protein–RNA interactions, Nucleic Acids Res, 49, W72, 10.1093/nar/gkab393
Nevo-Caspi, 2011, A-to-I RNA editing is induced upon hypoxia, Shock, 35, 585, 10.1097/SHK.0b013e31820fe4b7
Vlachogiannis, 2021, Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease, J Mol Cell Cardiol, 160, 111, 10.1016/j.yjmcc.2021.07.005
Yang, 2015, PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas, Cell Mol Life Sci, 72, 4383, 10.1007/s00018-015-1938-7
Chung, 2018, Human ADAR1 prevents endogenous RNA from triggering translational shutdown, Cell, 172, 811, 10.1016/j.cell.2017.12.038
Nie, 2005, ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing, Mol Cell Biol, 25, 6956, 10.1128/MCB.25.16.6956-6963.2005
Shi, 2017, Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma, Cell Death Dis, 8, 10.1038/cddis.2017.556
Zhang, 2020, Circ-calm4 serves as an miR-337-3p sponge to regulate Myo10 (Myosin 10) and promote pulmonary artery smooth muscle proliferation, Hypertension, 75, 668, 10.1161/HYPERTENSIONAHA.119.13715
Jiang, 2021, Circular RNA Calm4 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis via the Circ-Calm4/miR-124-3p/PDCD6 axis, Arterioscler Thromb Vasc Biol, 41, 1675, 10.1161/ATVBAHA.120.315525
Ma, 2020, circRNA CDR1as promotes pulmonary artery smooth muscle cell calcification by upregulating CAMK2D and CNN3 via sponging miR-7-5p, Mol Ther Nucleic Acids, 22, 530, 10.1016/j.omtn.2020.09.018
Yuan, 2021, Impact of circGSAP in peripheral blood mononuclear cells on idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, 203, 1579, 10.1164/rccm.202005-2052LE
González-Magaña, 2020, Human PCNA structure, function and interactions, Biomolecules, 10, 570, 10.3390/biom10040570
Xiong, 2018, N(1)-Methyladenosine methylome in messenger RNA and non-coding RNA, Curr Opin Chem Biol, 45, 179, 10.1016/j.cbpa.2018.06.017
Zhang, 2019, Elevated serum circ_0068481 levels as a potential diagnostic and prognostic indicator in idiopathic pulmonary arterial hypertension, Pulm Circ, 9, 10.1177/2045894019888416